Eutelsat Communications SA (ETL)
Euronext Paris · France · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 1.769 |
|---|---|
| 52-week range | 1.354 – 4.556 |
| Return, 1 month / 3 months | −0.0% / −14.5% |
| Return, 1 year / 3 years | −39.1% / −47.0% |
| Trend | Below its 200-day average |
| RSI (14) | 54 |
| Volatility (1 year) | 70.7% |
| Worst drawdown (1 year) | -69.6% |
| Average daily value traded | 4.83M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Eutelsat Communications is a satellite communications operator based in Paris, France. It owns and operates a fleet of satellites in geostationary orbit and provides capacity and services to broadcasters, telecom operators, internet service providers, enterprises and government agencies. Its services support television broadcasting, broadband connectivity in areas poorly served by terrestrial networks, and data and mobile connectivity for maritime, aviation and other customers across Europe, Africa, the Middle East and other regions.
Eutelsat Communications SA trades under the code ETL on the Euronext Paris in France, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Eutelsat Communications SA (ETL) trades on the Euronext Paris in France. It last closed at EUR 1.769 on 23 October 2026.
Its price-based Market X-Ray is 30 out of 100 (a weak price profile), ranking 502 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 39.1% and over the last three months it fell 14.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 16 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -22.7% | ||
| From 52-week high | -60.8% | ||
| Momentum | 22 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -14.5% | ||
| 6-month return | -38.8% | ||
| 12-month return, skipping the last month | -39.0% | ||
| Stability (higher is calmer) | 17 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 70.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -69.6% | ||
| Liquidity | 88 · Strong | Trades actively. | |
| Average daily value traded | 4.83M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +0.1% |
|---|---|
| 1 month | −0.0% |
| 3 months | −14.5% |
| 6 months | −38.8% |
| 1 year | −39.1% |
| 3 years | −47.0% |
| 5 years | −78.4% |
Signals
| 50-day / 200-day average | 1.743 / 2.288 |
|---|---|
| Golden / death cross (60 days) | Death, 53 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.128 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Nov 2022 | EUR 0.9300 |
| 16 Nov 2021 | EUR 0.9300 |
| 20 Nov 2020 | EUR 0.8900 |
| 21 Nov 2019 | EUR 1.2700 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.